Blocking Cellular Recycling Cuts Psoriasis Inflammation
Preclinical evidence links autophagy inhibition to reduced psoriatic inflammation. The cellular recycling pathway emerges as a candidate target in a biologics-saturated market.
Topic
Topic
Preclinical evidence links autophagy inhibition to reduced psoriatic inflammation. The cellular recycling pathway emerges as a candidate target in a biologics-saturated market.
A new review identifies IL-17 signaling as the mechanistic link between psoriasis and cardiometabolic risk, connecting plaque bio…
Pfizer's investigational IL-17 inhibitor tilrekimig produced a significant skin clearance signal in a Phase 2 atopic dermatitis t…
A Frontiers case report documents successful xeligekimab treatment of refractory generalized pustular psoriasis in two patients,…
A Cureus case series documents successful psoriasis treatment with bimekizumab in two patients whose disease proved hard to treat…